A5031233244- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Venous Thromboembolism Diagnosis and Management
- Cardiac electrophysiology and arrhythmias
- Liver Diseases and Immunity
- Gallbladder and Bile Duct Disorders
- Liver Disease Diagnosis and Treatment
- Acute Myocardial Infarction Research
- Health Systems, Economic Evaluations, Quality of Life
University Medical Center Groningen
2022-2024
University of Groningen
2023
The University of Adelaide
2020
Creative Research Enterprises (United States)
2020
Abstract Aims The recent 4S-AF (scheme proposed by the 2020 ESC AF guidelines to address stroke risk, symptom severity, severity of burden and substrate provide a structured phenotyping patients in clinical practice guide therapy assess prognosis) scheme has been as characterize with atrial fibrillation (AF). We aimed whether predicts progression self-terminating AF. Methods results analysed 341 included well-phenotyped Reappraisal Atrial Fibrillation: Interaction between HyperCoagulability,...
Abstract Introduction Concerns exist of women underrepresentation in atrial fibrillation (AF) studies, potentially limiting the generalisability study findings to with AF. We assessed participation AF clinical studies performed at a tertiary care centre Northern Netherlands. Methods Eight screening logs were available for analysis. To identify sex-specific differences, patient inclusion and exclusion reasons assessed. Participation-to-prevalence ratios (PPRs) calculated evaluate...
Background Sex differences in atrial fibrillation (AF) are observed terms of comorbidities, symptoms, therapies received, AF progression and cardiovascular complications. Methods We assessed the prevalence determinants progression, as well clinical characteristics quality life (QoL), between women men with paroxysmal included RACE V (Reappraisal Atrial Fibrillation: Interaction hyperCoagulability, Electrical remodeling, Vascular Destabilisation Progression AF) study. At baseline, extensive...
Objectives Pulmonary vein isolation (PVI) is widely accepted as an effective and safe treatment for symptomatic atrial fibrillation (AF). However, data on sex-related differences associations with clinical outcome safety of PVI cryoballoon ablation are limited. We sought to compare sexrelated efficacy identify outcomes. Methods results included 650 consecutive patients AF undergoing at our institution between 2013 2017. The was the first documented recurrence (>30 s) AF, flutter or...
Abstract Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main source(s): support from the Netherlands Cardiovascular Research Initiative: an initiative with Dutch Heart Foundation, CVON 2014-9: Reappraisal Atrial Fibrillation: interaction between hyperCoagulability, Electrical remodelling, and Vascular destabilisation in progression AF (RACE V). Purpose To assess whether 4S-AF scheme predicts progression, cardiovascular hospitalizations mortality...